FR2335222A1 - ETHERIFIED DERIVATIVES OF CLAVULANIC ACID, THEIR PREPARATION AND THERAPEUTIC COMPOSITIONS, CONTAINING - Google Patents

ETHERIFIED DERIVATIVES OF CLAVULANIC ACID, THEIR PREPARATION AND THERAPEUTIC COMPOSITIONS, CONTAINING

Info

Publication number
FR2335222A1
FR2335222A1 FR7638152A FR7638152A FR2335222A1 FR 2335222 A1 FR2335222 A1 FR 2335222A1 FR 7638152 A FR7638152 A FR 7638152A FR 7638152 A FR7638152 A FR 7638152A FR 2335222 A1 FR2335222 A1 FR 2335222A1
Authority
FR
France
Prior art keywords
preparation
therapeutic compositions
clavulanic acid
etherified derivatives
etherified
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7638152A
Other languages
French (fr)
Other versions
FR2335222B1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoire Glaxo Wellcome SA
Glaxo Laboratories Ltd
Original Assignee
Laboratoires Glaxo SA
Glaxo Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Glaxo SA, Glaxo Laboratories Ltd filed Critical Laboratoires Glaxo SA
Publication of FR2335222A1 publication Critical patent/FR2335222A1/en
Application granted granted Critical
Publication of FR2335222B1 publication Critical patent/FR2335222B1/fr
Granted legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/429Thiazoles condensed with heterocyclic ring systems
    • A61K31/43Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D503/00Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
FR7638152A 1975-12-17 1976-12-17 ETHERIFIED DERIVATIVES OF CLAVULANIC ACID, THEIR PREPARATION AND THERAPEUTIC COMPOSITIONS, CONTAINING Granted FR2335222A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB51688/75A GB1573503A (en) 1975-12-17 1975-12-17 Clavulanic acid derivatives

Publications (2)

Publication Number Publication Date
FR2335222A1 true FR2335222A1 (en) 1977-07-15
FR2335222B1 FR2335222B1 (en) 1982-06-11

Family

ID=10461003

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7638152A Granted FR2335222A1 (en) 1975-12-17 1976-12-17 ETHERIFIED DERIVATIVES OF CLAVULANIC ACID, THEIR PREPARATION AND THERAPEUTIC COMPOSITIONS, CONTAINING

Country Status (10)

Country Link
JP (1) JPS5293792A (en)
AU (1) AU2064576A (en)
BE (1) BE849475A (en)
DE (1) DE2657048A1 (en)
DK (1) DK565676A (en)
FR (1) FR2335222A1 (en)
GB (1) GB1573503A (en)
NL (1) NL7613965A (en)
SE (1) SE7614181L (en)
ZA (1) ZA767496B (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2364216A1 (en) * 1976-09-09 1978-04-07 Glaxo Lab Ltd Clavulanic acid derivs. - for use as beta-lactamase inhibitors for antibiotics
FR2369281A1 (en) * 1976-10-30 1978-05-26 Beecham Group Ltd B-LACTAM CYCLE COMPOUNDS FOR USE AS MEDICINAL PRODUCTS
FR2372837A1 (en) * 1976-12-03 1978-06-30 Beecham Group Ltd NEW ETHERS OF CLAVULANIC ACID, USED AS MEDICINAL PRODUCTS
FR2373545A1 (en) * 1976-12-11 1978-07-07 Beecham Group Ltd PROCESS FOR THE PREPARATION OF ETHERS FROM CLAVULANIC ACID
FR2383184A1 (en) * 1977-03-10 1978-10-06 Beecham Group Ltd ETHERS PREPARATION PROCESS
WO1997010247A1 (en) * 1995-09-15 1997-03-20 Smithkline Beecham P.L.C. Clavulanic acid derivatives for treating atherosclerosis

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0024123B1 (en) * 1979-08-11 1983-03-16 Beecham Group Plc Process for the preparation of derivatives of clavulanic acid

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2364216A1 (en) * 1976-09-09 1978-04-07 Glaxo Lab Ltd Clavulanic acid derivs. - for use as beta-lactamase inhibitors for antibiotics
FR2369281A1 (en) * 1976-10-30 1978-05-26 Beecham Group Ltd B-LACTAM CYCLE COMPOUNDS FOR USE AS MEDICINAL PRODUCTS
FR2372837A1 (en) * 1976-12-03 1978-06-30 Beecham Group Ltd NEW ETHERS OF CLAVULANIC ACID, USED AS MEDICINAL PRODUCTS
FR2373545A1 (en) * 1976-12-11 1978-07-07 Beecham Group Ltd PROCESS FOR THE PREPARATION OF ETHERS FROM CLAVULANIC ACID
FR2383184A1 (en) * 1977-03-10 1978-10-06 Beecham Group Ltd ETHERS PREPARATION PROCESS
WO1997010247A1 (en) * 1995-09-15 1997-03-20 Smithkline Beecham P.L.C. Clavulanic acid derivatives for treating atherosclerosis

Also Published As

Publication number Publication date
FR2335222B1 (en) 1982-06-11
ZA767496B (en) 1978-02-22
DE2657048A1 (en) 1977-06-23
JPS5293792A (en) 1977-08-06
SE7614181L (en) 1977-06-18
AU2064576A (en) 1978-06-22
DK565676A (en) 1977-06-18
NL7613965A (en) 1977-06-21
GB1573503A (en) 1980-08-28
BE849475A (en) 1977-06-16

Similar Documents

Publication Publication Date Title
BE842310A (en) DERIVATIVES OF THIENO-PYRIDINE, THEIR PREPARATION PROCESS AND THERAPEUTIC COMPOSITION CONTAINING THEM
FR2331352A1 (en) STABLE COMPOSITIONS OF ERYTHROCYTES, THEIR PREPARATION PROCESS AND THEIR APPLICATION
FR2281340A1 (en) DERIVATIVES OF FOLIC ACID, THEIR PREPARATION PROCESS AND THEIR APPLICATION
BE846081A (en) NEW DERIVATIVES OF AMIDOXIMES, THEIR PREPARATION AND COMPOSITIONS CONTAINING
BE801246A (en) NEW DERIVATIVES OF QUINALDIIC ACID AND THEIR PREPARATION
BE845271A (en) NEW DERIVATIVES OF AMINO-4 QUINOLEINE, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATIONS
FR2343730A1 (en) DERIVATIVES OF AMIDINOFORMIC ACID OR AMIDINOSULFINIC ACID, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FR2335222A1 (en) ETHERIFIED DERIVATIVES OF CLAVULANIC ACID, THEIR PREPARATION AND THERAPEUTIC COMPOSITIONS, CONTAINING
BE878020A (en) N-SUBSTITUTED DERIVATIVES OF AZIRIDINE-2-CARBOXYLIC ACID IMMUNOSTIMULATORS, METHODS OF PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FR2334681A1 (en) NEW LYSERGIC ACID DERIVATIVES AND THEIR PREPARATION
FR2353556A1 (en) CLAVULANIC ACID DERIVATIVES, THEIR PROCESS OF PREPARATION AND THEIR THERAPEUTIC APPLICATION
FR2320090A1 (en) NEW DERIVATIVES OF INDOLE, THEIR PREPARATION AND THEIR APPLICATION AS MEDICINAL PRODUCTS
FR2310132A1 (en) 14B-HYDROXY-3-DESOXYCARDENOLIDES AND ANALOGUES THEREOF, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
BE849177A (en) THIADIAZOLYL DERIVATIVES OF 7-ACYLAMIDO-3-CEPHEME-4-CARBOXYLIC ACID AND THEIR PREPARATION
PT65574B (en) NOVEL DERIVATIVES OF OXADIAZINE-1,2,4-ONE-5 PREPARATION THEREOF AND COMPOSITIONS CONTAINING SAME
BE843115A (en) PHARMACEUTICAL COMPOSITIONS CONTAINING HETEROCOLLOIDAL DEBRYCINE AND THEIR PREPARATION PROCESS
FR2299859A1 (en) GLYCYRRHETINIC ACID DERIVATIVES, THEIR PROCESS OF PREPARATION AND THEIR APPLICATION
FR2521142B1 (en) NOVEL N-METHANESULFONIC DERIVATIVES OF DEMETHYL-3-O ISTAMYCIN B, THEIR PREPARATION AND THERAPEUTIC COMPOSITIONS CONTAINING THE SAME
FR2283670A1 (en) 19,20-BIS-NOR-PROSTANOIC ACID DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
BE863802A (en) NEW DERIVATIVES OF EVERNINOMICINE, THEIR METHODS OF PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAID DERIVATIVES
FR2293429A2 (en) NEW DERIVATIVES OF IMINO-ISOINDOLINONE FOR USE AS PIGMENTS AND THEIR PREPARATION
FR2308365A2 (en) DERIVATIVES OF HYDROXY-9 ELLIPTICIN AND THEIR THERAPEUTIC APPLICATION
FR2326180A1 (en) OXANILIC ACID DERIVATIVES AND THEIR PREPARATION
BE792515A (en) NEW DERIVATIVES OF LYSERGIC ACID, THEIR PREPARATION AND THEIR APPLICATION AS MEDICINAL PRODUCTS
BE860042A (en) NEW DERIVATIVES OF CLAVULANIC ACID, THEIR PREPARATION AND COMPOSITIONS IN CONTAINING.

Legal Events

Date Code Title Description
TP Transmission of property
ST Notification of lapse